These findings implied that, in addition to the respective pathogenic mechanism of these two haematological diseases, a possible common mechanism may govern the terminal stage, namely the malignant myeloid progression, and wherein BMI1 seemed to play a pivotal role. The gene discussed is BMI1; the disease is hematologic disorder.